RETRACTION: Lin28 Induces Resistance to Anti‐Androgens via Promotion of AR Splice Variant Generation

Détails bibliographiques
Format:	Artículo Open Access
Publié:	Wiley 2026
Sujets:	The Prostate
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

RETRACTION: Interleukin‐4 Activates Androgen Receptor Through CBP/p300
Publié: (2025)

Deciphering Resistance: Beyond the Androgen Paradigm; Report From the 2025 Coffey‐Holden Prostate Cancer Academy Meeting
par: Tanya Stoyanova, et autres
Publié: (2025)

Androgen Deprivation Therapy: Mitochondrial Dysfunction and Metabolic Impacts in Prostate Cancer
par: Yu‐Hsiang Lin, et autres
Publié: (2025)

Evaluation of Second‐Line Treatment for Castration‐Resistant Prostate Cancer following the Administration of Upfront Androgen Receptor Signaling Inhibitors
par: Kazuro Kikkawa, et autres
Publié: (2024)

Efficacy, Safety, and Cost‐Effectiveness of Reduced versus Full Initial Doses of Androgen Receptor Signaling Inhibitors in Non‐Metastatic Castration‐Resistant Prostate Cancer: A Multicenter Retrospective Study
par: Himawari Asanuma, et autres
Publié: (2026)

pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post‐Initiation of Androgen Deprivation Therapy
par: Piotr Bialas, et autres
Publié: (2024)

Transcriptomic Signatures of Monocyte‐Derived Macrophages Associate With Androgen Receptor Pathway Inhibitor Progression in Prostate Cancer
par: Marina Nasrin Sharifi, et autres
Publié: (2025)

Therapeutic Exhaustion After Upfront Androgen Receptor Signaling Inhibitor: A Hidden Determinant of Post‐CRPC Survival
par: Shengyi Chen, et autres
Publié: (2026)

Androgen‐Deprivation Therapy and Dietary Habits Influence the Gut Microbial Environment in Patients With High‐Risk Localized Prostate Cancer
par: Masanori Ishida, et autres
Publié: (2025)

Efficacy and Predictive Factors Analysis of Androgen Deprivation Plus Novel Hormone Therapy as Neoadjuvant Treatment for High‐Risk Prostate Cancer
par: Hanyang Tao, et autres
Publié: (2024)

Immunohistochemical Analysis of Androgen Receptor Expression Predicts the Prognosis of Metastatic Castration‐Sensitive Prostate Cancer Patients Receiving Abiraterone Acetate
par: Mitsuhisa Nishimoto, et autres
Publié: (2025)

Impact of the Nadir Androgen Receptor Signaling Inhibitor‐Derived Integrative Response Model in Real‐World Patients With Metastatic Castration‐Sensitive Prostate Cancer
par: Kazuma Yukihiro, et autres
Publié: (2026)

Long‐Term Follow‐Up of Neoadjuvant Enzalutamide Plus Androgen Deprivation Therapy in Localized Prostate Cancer: A Secondary Analysis of a Neoadjuvant Feasibility Trial
par: Braden Millan, et autres
Publié: (2025)

Impact of Intraprostatic Simultaneous Integrated Boost on Long‐Term Outcomes in Unfavorable Intermediate‐Risk Prostate Cancer Treated With Dose‐Escalated Radiotherapy and Short‐Term Androgen Deprivation Therapy
par: Cem Onal, et autres
Publié: (2026)

Prostate Cancer Cells With the AR‐Low and EMT‐High Phenotype Are Vulnerable to NAD+ Synthesis Inhibitors
par: Hyun‐Kyung Ko, et autres
Publié: (2025)

Significant Effect of Carbon‐Ion Radiation Therapy Combined With Androgen Deprivation on Biochemical Recurrence Rates in High‐Risk Prostate Cancer Patients: A Two‐Center Controlled Trial Compare With X‐Ray External Beam Radiation Therapy
par: Xue Zhao, et autres
Publié: (2024)

LIAS Promotes Cuproptosis in Prostate Cancer Cells by Suppressing Glycolysis via the p53 Signaling Pathway
par: Zhe Tang, et autres
Publié: (2025)

Castration Resistance Accelerates Prostate Cancer Kinetics
par: Sheila Jonnatan, et autres
Publié: (2026)

Understanding Enzalutamide‐Resistance Based on a Functional Single‐Cell Approach
par: Changhui Xue, et autres
Publié: (2025)

Establishment and Characterization of Patient‐Derived Xenograft Organoids for Personalized Treatment of Castration‐Resistant Prostate Cancer
par: Takuro Sunada, et autres
Publié: (2026)

Restoration of Mitochondrial Function: A Metabolic Perspective on “Directed Evolution” in Castration‐Resistant Prostate Cancer
par: Po‐Jung Su, et autres
Publié: (2026)

Probenecid and Eugenol Mitigate Testosterone Induced Benign Prostatic Hyperplasia by Targeting Uric Acid‐Induced Inflammation and Pro‐Survival Pathways
par: Nibrass Taher Abdali, et autres
Publié: (2025)

Directed Evolution Restored Castrate Sensitivity in a Patient With Castrate Resistant Metastatic Prostate Cancer
par: Robert A. Gatenby, et autres
Publié: (2025)

Muscadine Grape Skin Extract in Biochemically Recurrent Prostate Cancer: A Randomized, Placebo‐Controlled, Biomarker‐Enriched Trial in Patients With the SOD2 Ala/Ala Variant
par: A. Mandl, et autres
Publié: (2025)

RETRACTION: Glyoxalase 2 Is Involved in Human Prostate Cancer Progression as Part of a Mechanism Driven By PTEN/PI3K/AKT/mTOR Signaling With Involvement of PKM2 and ERα
Publié: (2024)

Association of Weight Loss and BMI on PSA Levels and Overall Survival in Veterans With Metastatic Castrate‐Resistant Prostate Cancer
par: Nicholas Fedele, et autres
Publié: (2025)

Towards Precision Oncology: A New Predictive Machine Learning Model for Early Progression to Castration Resistant Prostate Cancer
par: Miguel Ángel Gómez‐Luque, et autres
Publié: (2025)

Comparative Effectiveness of First‐Line Treatments for Castration‐Resistant Prostate Cancer: A Large‐Scale Retrospective Study in Japan
par: Akihito Hashizume, et autres
Publié: (2025)

Real‐World Overall Survival Comparison of Enzalutamide and Abiraterone In First‐ and Second‐Line Setting of Metastatic Castration‐Resistant Prostate Cancer
par: András Horváth, et autres
Publié: (2025)

Comprehensive Genomic Profiling Testing for Castration‐Resistant Prostate Cancer in Advanced Elderly Patients: A Single‐Center Retrospective Cohort Study
par: Takafumi Fukushima, et autres
Publié: (2025)

A Phase II, Single Arm, Multicentre Trial of Triamcinolone With a GnRH Analog for Castrate‐Resistant Prostate Cancer (TRICREST)
par: Kenrick Ng, et autres
Publié: (2025)

Outcome of Subsequent Therapies After 177Lu‐Vipivotide Tetraxetan for Metastatic Castrate‐Resistant Prostate Cancer: A Tertiary Cancer Center Experience
par: Meryam Losee, et autres
Publié: (2025)

PRMT5:MEP50 Are Mediators of Treatment‐Induced Neuroendocrine Differentiation in Prostate Cancer
par: Hye Seung Nam, et autres
Publié: (2025)

Efficacy and Feasibility of Cabazitaxel for Very Elderly Patients of ≥ 80 Years of Age With Metastatic Castration‐Resistant Prostate Cancer: A Real‐World Multi‐Intuitional Analysis
par: Kotaro Suzuki, et autres
Publié: (2025)

c‐Kit‐Mediated PI3K/AKT and Wnt/β‐Catenin Signaling Drives Resistance to 5α‐Reductase Inhibitors in Benign Prostatic Hyperplasia
par: Jun Zhu, et autres
Publié: (2025)

Comments on the Study “Evaluating the Efficacy of Barley Water in Alleviating Radiotherapy‐Induced Dysuria in Prostate Cancer Patients”
par: Leibo Wang, et autres
Publié: (2026)

Baseline Imaging Derived Factors of Response Following [225Ac]Ac‐J591 Therapy in Metastatic Castration‐Resistant Prostate Cancer: A Lesion Level Analysis
par: Judith Stangl‐Kremser, et autres
Publié: (2025)

Dorsomorphin Suppresses EMT to Reduce AR‐Negative Prostate Cancer Metastasis by Synergistically Antagonizing JAK2/STAT3 and Gli2‐Independent Shh Activation
par: Dongzhang Li, et autres
Publié: (2025)

Evaluating the Efficacy of Barley Water in Alleviating Radiotherapy‐Induced Dysuria in Prostate Cancer Patients: A Randomized Placebo‐Controlled Trial
par: Vida Nazari, et autres
Publié: (2025)

Valosin‐Containing Protein (VCP/p97) Mediates Neuroendocrine Differentiation in Prostate Cancer Cells Through Pim1 Signaling Inducing Autophagy
par: K. K. Sruthi, et autres
Publié: (2025)

Documents similaires

Documents similaires